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In Traditional Chinese Medicine (TCM), patients with Rheumatoid Arthritis (RA) can be classiﬁed into two main patterns: cold-
pattern and heat-pattern. This paper identiﬁed the network-based gene expression biomarkers for both cold- and heat-patterns of
RA. Gene expression proﬁlings of CD4+ T cells from cold-pattern RA patients, heat-pattern RA patients, and healthy volunteers
were obtained using microarray. The diﬀerentially expressed genes and related networks were explored using DAVID, GeneSpring
software, and the protein-protein interactions (PPI) method. EIF4A2, CCNT1, and IL7R, which were related to the up-regulation
of cell proliferation and the Jak-STAT cascade, were signiﬁcant gene biomarkers of the TCM cold pattern of RA. PRKAA1, HSPA8,
and LSM6, which were related to fatty acid metabolism and the I-κB kinase/NF-κB cascade, were signiﬁcant biomarkers of the
TCM heat-pattern of RA. The network-based gene expression biomarkers for the TCM cold- and heat-patterns may be helpful for
the further stratiﬁcation of RA patients when deciding on interventions or clinical trials.
1.Introduction
Rheumatoid arthritis (RA) is a systemic autoimmune disease
characterized by chronic inﬂammation throughout the body,
particularly in diarthrodial joints [1, 2], and inﬂammatory
cell inﬁltration, including activated CD4+ T cells in periph-
eral blood [3]. There is substantial evidence that CD4+
Tcellsplayakeyroleininﬂammatoryprocessesinthepatho-
genesis of RA [4, 5] through their ability to stimulate the
secretion of proinﬂammatory cytokines, which induces im-
munoglobulinproductionandmatrixmetalloproteinasesec-
retion and causes osteoclastogenesis [6]. A hallmark patho-
logical feature of RA is the inﬁltration and accumulation of
T cells in the synovium of joints [7]. Because the shared
epitope in human leukocyte antigen-DR genes is found in
approximately80%ofRApatients,dysregulatedCD4+T-cell
activation and function have been investigated based on
available genetic predisposition evidence [8, 9].
Pattern classiﬁcation, a key aspect of traditional Chinese
medicine (TCM) therapeutic theory, is based on symptoms,
tongue appearance, and pulse feelings [10]. The eﬃcacy of
TCM is based entirely on pattern diﬀerentiation because the
pattern guides the prescription [11–13]. An increasing num-
ber of medical researchers are recognizing that the combi-
nation of disease diagnosis in biomedicine and pattern clas-
siﬁcation in TCM is essentialfor clinical practice. This model
is commonly practiced in China because it produces positive
clinical eﬀects [14]. In many clinical studies that emplo-
yed TCM pattern classiﬁcation, desirable outcomes were
achieved [15–23]. Moreover, the correlations between TCM
patterns and biomedical parameters are receiving an increas-
ing amount of attention during the mechanism exploration
step of TCM pattern classiﬁcation. Such correlations include
the linkage between sex hormones and Kidney deﬁciency
syndrome in chronic nephritis [24], the linkage between the
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rheumatoid arthritis (RA) [25], the association between
the Qi-Yin deﬁciency syndrome in type 2 diabetes mellitus
(T2DM) patients with macroangiopathy and the apolipo-
protein E (APOE) E4 and E3 genotypes [26], the correlation
between the serum level of eosinophil cationic protein (ECP)
in asthmatic patients and the development of “heat” synd-
romemanifestations[27],andthecloserelationshipbetween
decreases in skin electrical conductance and the severity of qi
vacuity [28]. Therefore, the classiﬁcation of diﬀerent TCM
patterns for speciﬁc diseases is important in both clinical
practice and related basic research.
RA patients can be classiﬁed into two main TCM pat-
terns:thecoldpatternandtheheatpattern.Manifestationsof
thecoldpatternaredescribedassevereﬁxedpaininajointor
muscle, pain relief upon warming, severe pain when cooling,
and a white tongue coating. In contrast, manifestations of
the heat pattern are characterized by severe pain, hot, red,
swollen and inﬂamed joints, pain relief upon cooling, severe
pain upon warming, fever, thirst, restlessness, deep-colored
urine, and a red tongue with a yellow coating [13, 29]. Our
previous study showed that the eﬀective rate of biomedical
combination therapy was higher in patients with a cold pat-
tern than in patients with a heat pattern (P < 0.01) [29].
These diﬀerent responses to treatment led to the hypothesis
that these patterns in TCM have their own speciﬁc markers.
An important part of systems biology, microarrays pro-
vide a powerful method for cataloging genes that are aﬀected
or mediated by a given disease [30, 31], such as RA [32, 33].
Increasingly informative software programs that aid in the
translation of these catalogues of genes from microarray
experiments into an understanding of disease pathology are
available. Biological systems are both redundant and highly
networked.Asaconsequence,manyfunctionallyinterrelated
genes tend to be aﬀected when the pathological eﬀects on a
given pathway are signiﬁcant. These pathways can be char-
acterized through a secondary analysis of diﬀerentially reg-
ulated gene sets using clustering and networking algorithms
and a visual analysis of gene function. Ma T coupled the clas-
sical TCM cold syndrome with methods from systems bio-
logy to explore the macro-and microsystems biology frame-
works of TCM syndromes. The results of this study indicate
that genes related to the cold syndrome play an essential role
in energy metabolism [34]. In a previous report, we used
microarray technology to reveal gene expression proﬁles in
CD4+ T cells and showed that 29 genes were diﬀerentially
regulatedinRApatientswithcoldandheatpatterns[35].We
identiﬁed the diﬀerentially expressed genes in the cold and
heatpatternRApatients.However,thecomparisonsbetween
the cold-pattern RA patients and healthy persons and those
between the heat-pattern RA patients and healthy persons
may be more important in identifying the biomarkers of the
cold and heat patterns. In the present study, we applied gene
expression proﬁling of peripheral CD4+ T cells from cold-
pattern RA patients, heat-pattern RA patients, and healthy
volunteers to identify the diﬀerentially expressed genes and
related networks for cold- and heat-pattern RA patients
based on the diﬀerences from healthy persons and to further
reveal the network-based biomarkers for the cold and heat
patterns using the Database for Annotation, Visualization
and Integrated Discovery (DAVID), the GeneSpring Soft-
ware, and a PPI (protein-protein interactions) analysis.
2.MaterialsandMethods
2.1. Patients. A total of 33 female RA patients from the
China-Japan Friendship Hospital and 12 healthy female vol-
unteers from the China Academy of Chinese Medical Science
in Beijing, aged 18 to 70 years old, participated in the study.
RA patients were eligible to participate if they had met the
AmericanCollegeofRheumatology(ACR)criteriaforRAfor
atleastoneyear,withafunctionalclassofI,II,orIII[36].Pa-
tients were diagnosed and classiﬁed into either the heat pat-
tern group or the cold pattern group according to TCM the-
ory using a questionnaire, a tongue examination, and pulse
diagnosis by 3 appointed TCM practitioners [13, 29]. Pa-
tients were included in the study only if the 3 practitioners
reported consistent results. This ensured that all of the selec-
ted patients had typical manifestations of the heat or cold
patterns according to TCM theory. Healthy females without
any diagnosed diseases were included as controls.
Patients who had continuously received nonsteroidal
anti-inﬂammatory corticosteroid drugs for more than 6
months or who had received these medicines within one
month were excluded from the study. Patients with severe
cardiovascular, lung, liver, kidney, mental, or blood system
diseases and women who were pregnant, breast-feeding, or
planning pregnancy in the next 8 months were excluded
from the study. A complete joint function and biochemical
function evaluation was available for all participants in the
study.
2.2. Sample Preparation. For the microarray, 8mL of venous
blood was collected in anticoagulation tubes from each of
the 45 participants (12 patients with the heat pattern, 21 pa-
tientswiththecoldpattern,and12healthyvolunteers)before
breakfast. CD4+ T cells were extracted and puriﬁed using
the RosetteSep Human CD4+ T Cell Enrichment Cocktail
(StemCell Technologies, Inc., Vancouver, Canada). Total
RNA was isolated from the CD4+ T cells using the Tri-
zol extraction method (Invitrogen, Carlsbad, Canada), as
describedbythemanufacturer.mRNAwasampliﬁedlinearly
using the MessageAmp aRNA Kit (Ambion, Inc., Austin,
USA), in accordance with the instructions of the manufac-
turer. cRNA was puriﬁed using an RNeasy Mini Kit (QIA-
G E N ,H i l d e n ,G e r m a n y )b a s e do nas t a n d a r dp r o c e d u r e .
2.3. Microarray Assay. A two-color whole Human Genome
Microarray Kit, 4 × 44K (Agilent Technologies) was used in
this study. Microarray hybridizations were performed on
labeled cRNAs. All arrays had the same labels: Cy3 for sam-
ples and Cy5 for controls. The arrays were incubated at 65◦C
for 17h in Agilent’s microarray hybridization chambers and
subsequently washed according to the Agilent protocol. The
arrays were scanned at a 5μm resolution using a Genepix
4000B scanner (Molecular Devices Corporation, Sunnyvale,
CA). Auto-photomultiplier tube (PMT) gains were adjusted
to obtain a ratio of Cy3 and Cy5 channel intensities. Scanned
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GenePix Pro Microarray Image Analysis Software. One assay
was completed for each sample, and biological replication
was adopted to reduce the systematic sources of variation
common in macroarray studies [37].
2.4. Statistics and Functional Analysis
2.4.1. Microarray Statistics. All of the data were analyzed
using the SAS9.1.3 statistical package (order no. 195557).
The data were normalized to correct for technical variations
among individual microarray hybridizations using the two-
step procedure described in detail by Jarvis and colleagues.
The signal intensity of each expressed gene was globally nor-
malized (LOWESS) using the R statistics program [38]. Any
ratio between two groups of more or less than 1:1.4 was
taken as the diﬀerential gene expression criteria. Statistical
signiﬁcance was tested using the Student’s t-test (P<0.05).
Changes greater than 1.4-fold (cold pattern to control group
or heat pattern to control group) were recorded as upregu-
lations, and those less than 1.4-fold (cold pattern to control
group or heat pattern to control group) were recorded as
downregulations. Other fold changes for gene expression
wererecordedasnormalexpression.Changesingeneexpres-
sion(1.4-foldchange)wererequiredinmorethan50%ofthe
patients. A chi-squared test was used for these comparisons
(P<0.05) and to identify similar and diﬀerent genes in
the cold and heat pattern groups of diﬀerentially expressed
genes.
Gene assemblages were obtained using a principal com-
ponents analysis and an iterated principal factor analysis. A
cut-oﬀvalueof1.5fortheforegroundandbackgroundsignal
ratios was used. The ﬂuorescence ratio for each spot was log-
transformed for normalization. A cluster analysis was per-
formed using Cluster 3.0 and Tree View software.
2.4.2. GeneSpring Analysis. A global comparison of all cell
lines was performed using GeneSpring GX v 7.3.1 (Agilent
Technologies) and the gene annotations available in March
2009 to ﬁnd diﬀerentially expressed genes in the majority of
resistant cell lines. Triplicate samples for the two conditions
(sensitive and resistant) in each of the seven cell lines (45
samples in total) were imported into one single experiment.
The expression of each gene was calculated as the ratio of
the value obtained for each condition relative to the control
condition after data normalization. The data were ﬁltered
using the control strength, and a control value was calculated
using the Cross-Gene Error Model on replicates based on the
average base/proportional value. Measurements with higher
control strengths are relatively more precise than measure-
ments with lower control strengths. Genes that did not reach
this value were discarded. Additional ﬁltering was performed
to identify the diﬀerentially expressed genes. We selected the
genes that displayed a P value corrected by a false discovery
rate (Benjamin and Hochberg FDR) of less than 0.05.
Of the signiﬁcantly diﬀerentially expressed RNA, only
genes with a greater than 1.4-fold increase or 1.4-fold dec-
rease in expression compared to the controls were used for
further analysis. All microarray data in this study are in
accordancewithMIAMEguidelines andhavebeendeposited
in the NCBI GEO database.
2.4.3. Gene Ontology and KEGG Pathway Analysis Using
DAVID. We used DAVID Bioinformatics Resources 6.7 (the
Database for Annotation, Visualization, and Integrated Dis-
covery) [39], “http://david.abcc.ncifcrf.gov/”, a comprehen-
sive set of functional annotation tools for understanding the
biological meaning behind large lists of genes, to obtain gene
ontology and KEGG pathway information for diﬀerential
genes between the cold pattern and control samples and bet-
ween the heat pattern and control samples. Diﬀerentially
expressed genes that were similar and diﬀerent between the
cold pattern and the control and between the heat pattern
and the control were compared. In the analysis, the control
wassetatthe0.01levelforthenumberoffalsepositivesusing
two statistics: False Detection Rate (FDR) and Bonferroni
correction (FWER).
2.4.4. Protein-Protein Interaction Analysis. PPIS are the basic
skeleton for the self-organization and homeostasis of living
organisms [40]. In this study, information on human PPI
networks from signiﬁcant genes was obtained from data-
bases, including the BIND, BIOGRID, DIP, HPRD, IntAct,
and MINT, and complemented with relationships that were
parsed from the literature using Agilent Literature Search.
ThePPInetworkwasvisualizedusingtheCytoscapesoftware
[41].
We integrated the databases and networks and used an
IPCA to analyze the characteristics of the networks. The
IPCA algorithm can detect highly connected regions or clus-
ters in the interactome network [42]. Interactomes with a
score greater than 2.0 and at least four nodes were taken as
signiﬁcant predictions.
Gene ontology categories were further analyzed to iden-
tify the function of each highly connected region generated
by the IPCA. The latest version of the Biological Network
Gene Ontology (BINGO) tool was used to statistically eva-
luate groups of proteins with respect to the existing annota-
tions of the Gene Ontology Consortium. The degree of func-
tionalenrichmentforagivenclusterwasquantitativelyasses-
sed (P value) using a hypergeometric distribution imple-
mented in the BINGO tool.
3. Results
3.1. Diﬀerential Gene Expression:RA with the Cold Pattern
versustheHealthyControlandRAwiththeHeatPatternversus
theHealthyControl. AcomparisonbetweenRApatientswith
the cold pattern and the healthy control revealed 35 diﬀeren-
tially regulated genes (Figure 1, Table 1). Among these diﬀe-
rentially regulated genes, 16 were upregulated (fold ≥ 1.4)
and 19 were downregulated (fold ≤ 1.4).
An analysis of RA patients with the heat pattern versus
the healthy control showed 21 diﬀerentially expressed genes
(Figure 1, Table 2); 15 were upregulated (fold ≥ 1.4), and 6
were downregulated (fold ≤ 1.4) (Figure 1, Table 2).
Six genes showed the same pattern of diﬀerential expres-
sion between the cold and control groups and between4 Evidence-Based Complementary and Alternative Medicine
Table 1: Diﬀerentially expressed genes in cold-pattern RA patient versus healthy control.
Gene name Deﬁnition Accession
no.
Cold/control
ratio
Upregulated gene (>1.4)
MMGT1 Membrane magnesium transporter 1 AL157477 1.70
TDRD7 Tudor domain containing 7 AB025254 1.56
SLC4A7 Solute carrier family 4, sodium bicarbonate Cotransporter, member 7 AF047033 1.54
MRPL28 Mitochondrial ribosomal protein L28 NM 006428 1.54
CCNT1 Cyclin T1 NM 001240 1.52
GTF3C6 General transcription factor IIIC, polypeptide 6, alpha 35kDa BC011593 1.49
BCL2A1 BCL2-related protein A1 NM 004049 1.45
TRIM22 Tripartite motif-containing 22 NM 006074 1.45
CTLA4 Cytotoxic T-lymphocyte-associated protein 4 AF414120 1.45
KLRAQ1 KLRAQ motif containing 1 BC011978 1.45
GBP3 Guanylate binding protein 3 AL136680 1.43
MIS12 MIS12, MIND kinetochore complex component, homolog (S. pombe)N M 024039 1.43
PDCD2 Programmed cell death 2 AJ420535 1.43
ATOX1 ATX1 antioxidant protein 1 homolog (yeast) NM 004045 1.43
PIGB Phosphatidylinositol glycan, class B NM 004855 1.41
NPEPPS Aminopeptidase puromycin sensitive NM 006310 1.41
Downregulated gene (<1:1.4)
Unknown Homo sapiens cDNA FLJ11459 ﬁs, clone HEMBA1001566 AK021521 0.59
Unknown Homo sapiens mRNA; cDNA DKFZp434I138 (from clone DKFZp434I138) AL122121 0.66
Unknown Homo sapiens clone 24629 mRNA sequence AF052160 0.66
ZNF330 Zinc ﬁnger protein 330 NM 014487 0.67
PLP2 Proteolipid protein 2 (colonic epithelium-enriched) NM 002668 0.68
PTGES2 Prostaglandin E synthase 2 NM 025072 0.68
PSMD8 Proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 NM 002812 0.68
IL7R Interleukin 7 receptor NM 002185 0.68
STMN3 Stathmin-like 3 NM 015894 0.68
ABCC10 ATP-binding cassette, sub-family C (CFTR/MRP), member 10 AK000002 0.69
ELAC2 ElaC homolog 2 (E. coli)N M 018127 0.69
PLEKHA1 Pleckstrin homology domain-containing, family A (phosphoinositide binding
speciﬁc) member 1 NM 021622 0.69
DCXR Dicarbonyl/L-xylulose reductase NM 016286 0.70
EIF4A2 Eukaryotic translation initiation factor 4A2 NM 001967 0.70
IL16 Interleukin 16 (lymphocyte chemoattractant factor) M90391 0.70
GRAMD1B GRAM domain containing 1B AB033027 0.71
LAGE3 L antigen family, member 3 NM 006014 0.71
TMEM80 Transmembrane protein 80 BC008671 0.71
SLIT3 Slit homolog 3 (Drosophila) AL122074 0.71
the heat and control groups (Table 3): MMGT1, TDRD7,
GTF3C6, BCL2A1, CTLA4,a n dPSMD8.E x c e p tf o rPSMD8,
which was downregulated, these genes were upregulated in
both the cold pattern and the heat pattern comparisons.
3.2. Pathway Analysis Using DAVID. The KEGG pathway
analysesofthesigniﬁcantlyexpressedgenesusing DAVIDare
shown in Tables 4, 5,a n d6. The six genes shared between the
cold pattern and the heat pattern comparisons were related
to the following pathways (Table 4): CAMs, T-cell receptor
signaling pathway, and the proteasome. CTLA4 participates
in the pathways of autoimmune thyroid disease, CAMs,
and the T-cell receptor signaling and rheumatoid arthritis
pathways. PSMD8 is one subunit of the proteasome. These
results showed that the RA patients with either the cold or
heat pattern had the same ﬁve pathways, which were disor-
dered compared to healthy persons. These were the common
points in the pathways of the cold and heat pattern compar-
isons.Evidence-Based Complementary and Alternative Medicine 5
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Figure 1: Cluster diagram of the expression of signiﬁcantly expressed genes in 21 RA patients with the cold pattern, 12 RA patients with
the heat pattern, and 12 healthy volunteers. Patients are indicated as vertical column headings, and gene symbols of transcripts are given in
horizontal rows. Red represents a relative expression greater than the median expression level across all samples, and green represents an ex-
pression level lower than the median. (a) Signiﬁcantly expressed genes between TCM cold-pattern RA patients and healthy control. (b) Sig-
niﬁcantly expressed genes between TCM heat-pattern RA patients and healthy control.
Compared to the heat pattern versus control analysis,
the cold pattern versus control analysis revealed that dif-
ferent pathways were related to the following diﬀeren-
tially expressed genes (Table 5): glycosylphosphatidylinositol
(GPI) anchor biosynthesis, arachidonic acid metabolism,
Jak-STAT signaling, hematopoietic cell lineage, primary im-
munodeﬁciency, cytokine-cytokine receptor interactions,
ABCtransporters,pentoseandglucuronateinterconversions,
and axon guidance. These pathways, which were related to
thediﬀerentiallyexpressedgenes,maybecharacteristicofthe
cold pattern.
The diﬀerentially expressed genes identiﬁed in the heat
pattern versus control group analysis were related to the fol-
lowing pathways (Table 6): antigen processing and presen-
tation, endocytosis, MAPK signaling, RNA degradation,
hematopoietic celllineage,complementandcoagulationcas-
cades, mTOR signaling, adipocytokine signaling, regulation
of autophagy, and insulin signaling. These results may reveal
characteristics of the heat pattern.
3.3. Results of Gene Ontology Analysis Using DAVID. The
GO-discovered categories using DAVID analysis for similar
and diﬀerent signiﬁcantly expressed genes between the cold
pattern and the heat pattern comparisons are shown in
Tables 7, 8,a n d9. As shown in Table 7, the six shared diﬀer-
entially expressed genes of the cold and heat pattern compar-
isons were predominantly grouped into functional classes of
protein binding and binding. BCL2A1, CTLA4,a n dPSMD8
belong to biological processes of negative cellular regula-
tion,andTDRD7,GTF3C6,andPSMD8arecellularconstitu-
ents of intracellular organelle lumens. The results of these
gene ontology analyses were common to the cold and heat
patterns.
Genes that were uniquely diﬀerentially expressed bet-
ween the cold pattern and the control were predominantly
grouped into functional classes of protein binding (18 genes)
and binding (22 genes) (Table 8) .Af e wg e n e sb e l o n g e dt o
interspecies interactions between organisms (IL16, EIF4A2,
and CCNT1), multiorganism processes (IL16, EIF4A2,
CCNT1, TRIM22), and the immune response (IL16, IL7R,
TRIM22,GBP3).SLC4A7 andDCXRarecellularconstituents
of the ribonucleoprotein complex.
As shown in Table 9, the genes that were uniquely diﬀer-
entially expressed between the heat pattern and the control6 Evidence-Based Complementary and Alternative Medicine
Table 2: Diﬀerentially expressed genes in heat-pattern RA patient versus healthy control.
Gene name Deﬁnition Accession no. Heat/control ratio
Up-regulated gene (>1.4)
CAMP Cathelicidin antimicrobial peptide NM 004345 2.33
MMGT1 Membrane magnesium transporter 1 AL157477 1.69
TDRD7 Tudor domain containing 7 AB025254 1.56
LSM6 LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae) NM 007080 1.54
CCDC55 Coiled-coil domain containing 55 NM 032141 1.54
GTF3C6 General transcription factor IIIC, polypeptide 6, alpha 35kDa BC011593 1.54
CD59 CD59 molecule, complement regulatory protein NM 000611 1.52
CTLA4 Cytotoxic T-lymphocyte-associated protein 4 AF414120 1.52
ASCC3 Activating signal cointegrator 1 complex subunit 3 AY013288 1.47
PRKAA1 Protein kinase, AMP-activated, alpha 1 catalytic subunit AK024252 1.45
BCL2A1 BCL2-related protein A1 NM 004049 1.45
TMEM60 Transmembrane protein 60 NM 032936 1.43
HSPA1A Heat shock 70kD protein 1A NM 005345 1.43
PARP9 Poly (ADP-ribose) polymerase family, member 9 NM 031458 1.43
HIST1H1C histone cluster 1, H1c NM 005319 1.43
Down-regulated gene (<1:1.4)
HSPA8 Heat shock 70kD protein 8 NM 006597 0.63
SLC43A3 Solute carrier family 43, member 3 NM 014096 0.67
Unknown Homo sapiens clone 24629 mRNA sequence AF052160 0.67
PSMD8 Proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 NM 002812 0.69
NCL Nucleolin NM 005381 0.70
LBH Limb bud and heart development homolog (mouse) NM 030915 0.71
Table 3: The same signiﬁcantly expressed genes found in the diﬀerences between the cold and control groups and between the heat and
control groups.
Gene name Deﬁnition Accession no.
Ratio in cold
versus
control
Ratio in heat
versus
control
MMGT1 Membrane magnesium transporter 1 AL157477 1.70 1.69
TDRD7 Tudor domain containing 7 AB025254 1.56 1.56
GTF3C6 General transcription factor IIIC, polypeptide 6, alpha 35kDa BC011593 1.49 1.54
BCL2A1 BCL2-related protein A1 NM 004049 1.45 1.45
CTLA4 Cytotoxic T-lymphocyte-associated protein 4 AF414120 1.45 1.52
PSMD8 Proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 NM 002812 0.68 0.69
were predominantly grouped into functional binding classes,
including nucleotide binding, ATP binding, adenyl ribonu-
cleotide binding, adenyl nucleotide binding, purine nucleo-
side binding, nucleoside binding, unfolded protein binding,
ribonucleotide binding, purine ribonucleotide binding, and
purine nucleotide binding. A few genes belonged to the bio-
logical stress response process, the biotic stimuli response,
the unfolded protein response, and the protein stimulus and
cellular constituent response of the ribonucleoprotein com-
plex.
The common point of GO-discovered categories in the
cold and heat pattern comparisons was the cellular con-
stituentoftheribonucleoproteincomplex.Thecharacteristic
molecular function is protein binding in the cold pattern,
whereas it is nucleoside and ribonucleotide binding in the
heat pattern.
3.4. Gene Function Using GeneSpring Analysis. The networks
in Figure 2 were constructed using the GeneSpring GX v
7.3.1 software, as described in the Methods Section, starting
with the lists of genes that were diﬀerently expressed between
the cold pattern and the control (network A) and between
theheatpatternandthecontrol(networkB).Thesenetworks
revealed the functions and biological processes of the signiﬁ-
cantly expressed genes.
CTLA4, PSMD8, and TDRD7 were in both the cold and
heat pattern comparisons, similar to the DAVID analysis
results. CTLA4 and CCNT1 are important centers of the coldEvidence-Based Complementary and Alternative Medicine 7
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Figure2:Networksofcold-andheat-patterncomparisonsbasedonGeneSpringGXv7.3.1software.(a)Diﬀerentlyexpressedgenesbetween
the cold pattern and the control. (b) Diﬀerently expressed genes between the heat pattern and the control. (c) Diﬀerently expressed genes
between the cold pattern and the control in T-cell regulation. (d) Diﬀerently expressed genes between the heat pattern and the control in
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Table 4: The pathways shared by the diﬀerently expressed genes of the cold pattern versus control and heat pattern versus control compari-
sons.
KEGG pathway Related genes Ratio in cold versus control Ratio in heat versus control
hsa05320: Autoimmune thyroid disease CTLA4 1.45 1.52
hsa04514: Cell adhesion molecules (CAMs) CTLA4 1.45 1.52
hsa04660: T cell receptor signaling pathway CTLA4 1.45 1.52
hsa05323: Rheumatoid arthritis CTLA4 1.45 1.52
hsa03050: Proteasome PSMD8 0.68 0.69
Table 5: The pathways related to the diﬀerently expressed genes between the cold pattern and control comparison.
KEGG pathway Related genes Ratio
hsa00563: Glycosylphosphatidylinositol (GPI) anchor biosynthesis PIGB 1.41
hsa00590: Arachidonic acid metabolism PTGES2 0.68
hsa04630: Jak-STAT signaling pathway IL7R 0.68
hsa04640: Hematopoietic cell lineage IL7R 0.68
hsa05340: Primary immunodeﬁciency IL7R 0.68
hsa04060: Cytokine-cytokine receptor interaction IL7R 0.68
hsa02010: ABC transporters ABCC10 0.69
hsa00040: Pentose and glucuronate interconversions DCXR 0.70
hsa04360: Axon guidance SLIT3 0.71
pattern networks, and they cooperated with the IL7R, IL16,
and EIF4A2 proteins and participated in the negative regu-
lation of T cells, T cell homeostasis, intracellular tyrosine,
Janus Kinase 3, RNA elongation, and transcription.
In the network of diﬀerently expressed genes between the
heat pattern and the control, CAMP, HSPA8, and HSPA1A
were highly connected with other diﬀerently expressed genes
and were related to the negative regulation of T cells, protein
refolding, keratinocyte migration, and neutrophil apoptosis.
Networks C and D revealed that the diﬀerently expressed
genes in the cold and heat pattern comparisons were related
to the regulation of T cells but in diﬀerent ways. In the cold
pattern, IL7R, CD80, and IL-6 processed the negative regu-
lation of T-cell activity and T-cell homeostasis through
CTLA4. However, in the heat pattern, except for CTLA4,
which was related to the negative regulation of T cell acti-
vation, CAMP, SOCS1, HSPA1A, and TLR7 participated in
T-cell-mediated immunity, macrophage activation, and ker-
atinocyte migration.
3.5. Results of PPI Analysis. The PPI networks of the sig-
niﬁcantly expressed genes between the cold pattern and the
control and between the heat pattern and the control are
showninFigure 3.Therewerefoursubnetworksforthecold-
patterncomparisonandfoursubnetworksfortheheatpatten
comparison. The gene ontology analyses of each subnetwork
are shown in Table 10.
The PPI subnetworks of the cold-pattern versus control
comparison (subnetworks A-D) revealed the seed nodes
EIFA2,CCNT1,andPSMD8andtheirrelatedproteins,which
were similar to the diﬀerently expressed genes in the afor-
mentioned analysis. The PPI subnetworks of the heat pattern
versus control comparison (subnetworks E-H) revealed the
seednodesPSMD8,HSPA8,LSM6,andPRKAB2,whic hw er e
also similar to the signiﬁcantly diﬀerently expressed genes in
the heat pattern and control comparison. The seed proteins
and subnetworks related to the gene ontology analysis re-
sults were matched with the KEGG pathways, the gene onto-
logy, and the functional analysis results using DAVID and
GeneSpring based on the diﬀerently expressed genes in the
cold- and heat-pattern comparisons (Table 10).
3.6. The Intersection Network between the Cold Pattern and
the Heat Pattern. Figure 4 shows the intersection network
between the cold pattern and the heat pattern, which in-
cludes the majority of diﬀerently expressed genes in the cold
and heat pattern comparisons. All subnetworks are shown in
Figures 3 and 4.
Based on the gene ontology analysis results (Table 10)
and the other results, Figure 5 was drawn to outline the net-
works of the cold and heat patterns and to reveal the rela-
tionships between the two patterns in the functional and
biological processes of the network.
Inthesenetworks,proteinubiquitinationandRNAsplic-
ing were the common biological processes in the TCM cold
and heat patterns of RA. The diﬀerent biomarkers for the
TCM cold and heat patterns of RA are obvious: the cold
pattern was related to the regulation of translation and the
Jak-STAT cascade, while the heat pattern was related to fatty
acidmetabolismandtheI-κBkinase/NF-κBcascade.Inaddi-
tion, protein ubiquitination, proliferation, and apoptosis re-
lated to the cell cycle are the biological process connections
between the cold pattern and the heat pattern. CTLA4 and
PSMD8 were the signiﬁcant biomarkers in both the cold and
heat patterns. The signiﬁcant biomarkers of the cold pattern
were EIF4A2, CCNT1, and IL7R, while the signiﬁcant bio-
markers of the heat pattern were PRKAA1, HSPA8, and
LSM6.Evidence-Based Complementary and Alternative Medicine 9
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Figure 3:ThePPIsubnetworksbasedonthediﬀerentlyexpressedgenesmadeupofhighlyconnectedregions.(a–d):Thesubnetworksofthe
cold pattern versus control comparison. (e–h): The subnetworks of the heat pattern versus control comparison. Diamonds represent seed
nodes. Cycles represent neighbor nodes. All edges represent interactions.
4. Discussion
In this study, we utilized software to identify network-based
gene expression biomarkers and biomarkers that were orga-
nizedbysetsofdiﬀerentiallyexpressedgenesthatweremem-
bers of established functional networks. Our major ﬁndings
werethenetwork-basedgeneexpressionbiomarkerpathways
that were similar and diﬀerent between the TCM cold-
pattern RA patients and the TCM heat-pattern RA patients.
The CAMs, T-cell receptor signaling pathway, and pro-
teasome could be related to both the TCM cold and heat pat-
terns in RA patients. Speciﬁcally, CTLA4 (cytotoxic T lym-
phocyte antigen 4), which was a seed gene in these pathways
and was up-regulated in both patterns, participates in the
pathways of CAMs and T-cell receptor signaling. The CTLA4
molecule is expressed on activated T lymphocytes and has
recently been identiﬁed as an important negative regulator
in autoimmune diseases. Quantitative alterations of CTLA4
contribute to autoimmune tissue destruction [43], and the
expressionof CTLA4playsadownregulatoryroleinrheuma-
toid articular inﬂammation. CTLA4 was also up-regulated
on T cells in patients with RA, and the increase in CTLA4
expression might exert a downregulation eﬀect on tumor
necrosis factor alpha and interleukin 1 beta production
[44]. CTLA4-Ig in activated macrophages induces signiﬁcant
down-regulation in the cellular production of IL-6, TNF-
alpha, IL1-beta, and TGF-beta for the treatment of RA [45].
In the GeneSpring analysis results, the functions of CTLA4
and its relationships with other immune molecules, such as
IL-16, IL-7R, FOXP3, and CD80, which participates in T-cell
homeostasis and the negative regulation of T-cell activation
in cold-pattern RA patients, were identiﬁed. In the heat pat-
tern RA patients, except for the negative regulation of T-cell
activation, CTLA4 participates in T-cell-mediated immunity,
macrophage activation, and keratinocyte migration with the
otherseedgenes,suchasCAMP,SOCS1,HSPA1A,andTLR9.10 Evidence-Based Complementary and Alternative Medicine
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Figure 4: The PPI network of functional relationships between the cold and heat patterns. Diamonds represent seed nodes. Cycles represent
neighbor nodes. All edges represent interactions. (a) Is the network speciﬁc to the cold pattern. (c) Is the network speciﬁc to the heat pattern.
(b)Isthecommonlysharednetworkofbothpatterns,whichislikelythecommonnetworkofRA.Thepartsbetween(a)and(b)andbetween
(b) and (c), as shown by arrows, are the connections between the highly condensed TCM pattern-related networks and the common shared
network.
Our study showed that CTLA4 is an important common
negativeregulatorinbothcold-andheat-patternRApatients
compared to healthy controls.
PSMD8(Proteasome(prosome,macropain)26Ssubunit,
non-ATPase, 8), a signiﬁcantly expressed gene in both cold-
and heat-pattern RA patients, is one subunit of a protein-
destroying apparatus that is involved in many essential cel-
lular functions, such as the regulation of the cell cycle, cell
diﬀerentiation, signal transduction pathways, antigen pro-
cessing for appropriate immune responses, stress signaling,
inﬂammatory responses, and apoptosis [46]. PSMD8 was
down-regulated in both cold- and heat-pattern RA patients
compared to healthy controls. The PPI analysis (Figure 3)
showed that in the subnetwork B of cold-pattern RA patients
and the subnetwork E of heat pattern RA patients, the
PSMD8-related family showed similar biological functions;Evidence-Based Complementary and Alternative Medicine 11
Table 6: The pathways related to the diﬀerently expressed genes between the heat pattern and control comparison.
KEGG pathway Related genes Ratio
hsa03040: Spliceosome LSM6, HSPA1A, HSPA8 1.54, 1.43, 0.63
hsa04612: Antigen processing and presentation HSPA1A, HSPA8 1.43, 0.63
hsa04144: Endocytosis HSPA1A, HSPA8 1.43, 0.63
hsa04010: MAPK signaling pathway HSPA1A, HSPA8 1.43, 0.63
hsa03018: RNA degradation LSM6 1.54
hsa04640: Hematopoietic cell lineage CD59 1.52
hsa04610: Complement and coagulation cascades CD59 1.52
hsa04150: mTOR signaling pathway PRKAA1 1.45
hsa04920: Adipocytokine signaling pathway PRKAA1 1.45
hsa04140: Regulation of autophagy PRKAA1 1.45
hsa05410: Hypertrophic cardiomyopathy (HCM) PRKAA1 1.45
hsa04910: Insulin signaling pathway PRKAA1 1.45
hsa05020: Prion diseases HSPA1A 1.43
hsa05130: Pathogenic Escherichia coli infection NCL 0.70
Table 7: GO-discovered categories for the same expressed genes in the cold versus control and heat versus control groups.
GO ID GO name Number
of genes P value Gene name
Biological process
GO:0048523 Negative regulation of cellular
process 3 0.1085 BCL2A1, CTLA4, PSMD8
GO:0048519 Negative regulation of biological
process 3 0.1264 BCL2A1, CTLA4, PSMD8
Cellular constituent
GO:0070013 Intracellular organelle lumen 3 0.0993 TDRD7, GTF3C6, PSMD8
Molecular function
GO:0005515 Protein binding 5 0.2392 TDRD7, BCL2A1, GTF3C6,
CTLA4, PSMD8
GO:0005488 Binding 6 0.3880 MMGT1, TDRD7, BCL2A1,
GTF3C6, CTLA4, PSMD8
it was involved in the regulation of protein ubiquitination
in the cell cycle. Therefore, in RA patients, the regulation of
protein ubiquitination in the cell cycle is down-regulated in
both cold- and heat-pattern patients. In PPI sub-networks C
and G, a similar biological process, RNA splicing, was obser-
ved in both cold-pattern and heat-pattern RA patients.
In TCM cold-pattern RA patients, pathways related to
GPI anchor biosynthesis, arachidonic acid metabolism, Jak-
STAT signaling, hematopoietic cell lineage, primary immun-
odeﬁciency, cytokine-cytokine receptor interaction, ABC
transporters, pentose and glucuronate interconversions, and
axon guidance were found. In these pathways, CCNT1, IL7R,
IL16, and EIF4A2 genes were included as the seeds.
CCNT1, or Cyclin T1, is a protein in the highly conserved
cyclin family, whose members are characterized by a dra-
matic periodicity in protein abundance throughout the cell
cycle. Cyclins function as regulators of CDK kinases. Diﬀe-
rent cyclins exhibit distinct expression and degradation pat-
terns, which contribute to the temporal coordination of each
mitotic event. Cyclin T1 is closely associated with CDK9
kinase and is a major subunit of the transcription elongation
factor p-TEFb. This cyclin and its kinase partner are involved
in the phosphorylation and regulation of the carboxy-ter-
minal domain (CTD) of the largest RNA polymerase II sub-
unit [47]. Cyclin T1 protein expression is highly regulated in
CD4+ T cells and macrophages. Cyclin T1 expression is
low in resting CD4+ T cells that have been isolated from
healthy donors, but upon T-cell activation, it is induced
by a mechanism that involves posttranscriptional regulation
[48, 49]. Cyclin T1 expression is also low in freshly isolated
monocytes, and it is up-regulated by a posttranscriptional
mechanism within one to twodays afterthe cellsarecultured
under conditions that allow for macrophage diﬀerentiation
[50]. However, after one to two weeks in culture, Cyclin T1
proteinexpressionisshutoﬀinmacrophagesbyproteasome-
mediated proteolysis. Treatment of macrophages with the
immunosuppressive cytokine IL-10 accelerates this protea-
some-mediated shut-oﬀ of Cyclin T1 [51]. Cyclin T1 can be
reinduced by activation with agents, such as LPS, which
indicates that the induction of Cyclin T1 is a component of
an innate immune response in maturemacrophages[52, 53].
In our study, CCNT1, which was up-regulated, participated12 Evidence-Based Complementary and Alternative Medicine
Table 8: GO-discovered categories for the genes that diﬀered between the cold pattern and the control.
GO ID GO name Number of
genes P value Gene name
Biological process
GO:0044419 Interspecies interaction between
organisms 3 0.0600 IL16, EIF4A2, CCNT1
GO:0051704 Multiorganism process 4 0.0692 IL16, EIF4A2, CCNT1, TRIM22
GO:0006955 Immune response 4 0.0714 IL16, IL7R, TRIM22, GBP3
Cellular constituent
GO:0005902 Ribonucleoprotein complex 2 0.0508 SLC4A7, DCXR
Molecular function
GO:0005515 Protein binding 18 0.0210
PLP2, ELAC2, PTGES2, IL16, STMN3, ATOX1, CCNT1,
NPEPPS, IL7R, TRIM22, MIS12, ZNF330, PDCD2,
SLIT3, LAGE3, EIF4A2, SLC4A7, DCXR
GO:0005488 Binding 22 0.0866
PLP2, ELAC2, PTGES2, IL16, STMN3, ATOX1, CCNT1,
ABCC10, NPEPPS, IL7R, TRIM22, MIS12, ZNF330,
PDCD2, SLIT3, MRPL28, LAGE3, EIF4A2, SLC4A7,
GBP3, DCXR, PLEKHA1
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Figure 5: The gene ontology relationship between the TCM cold
and heat patterns in RA. Cycles on the left represent cold-pattern-
related biological processes. Cycles on the right represent heat-pat-
tern-related biological processes. Cycles in the middle represent the
biological processes common to the cold and heat patterns. Arrows
represent the direction of the regulation of diﬀerently expressed
genes: up signiﬁes up-regulation, and down signiﬁes down-regula-
tion.
inRNAtranscriptionandproteinubiquitinationincold-pat-
ternRApatients,butnochangewasobservedinheat-pattern
RA patients.
IL7R (Interleukin 7 receptor) participated in the Jak-
STAT signaling pathway, hematopoietic cell lineage, primary
immunodeﬁciency, and cytokine-cytokine receptor interac-
tions in the KEGG pathway database for cold-pattern RA pa-
tients. The protein encoded by this gene is a receptor for
interleukin 7 (IL7). The function of this receptor requires the
interleukin 2 receptor gamma chain (IL2RG) ,ac o m m o n
gamma chain shared by the receptors of various cytokines,
including interleukins 2, 4, 7, 9, and 15. This protein plays a
critical role in the V (D) J recombination during lymphocyte
development. This protein also controls the accessibility of
the TCR gamma locus by STAT5 and histone acetylation.
Knockout studies in mice suggest that apoptosis blockade is
anessentialfunctionofthisproteinduringthediﬀerentiation
and activation of T lymphocytes. The functional defects in
this protein may be associated with the pathogenesis of
severecombinedimmunodeﬁciency(SCID)[54].NF-κB-de-
pendent gene expression in peripheral leukocytes is highly
correlatedwithRAactivity,asmeasuredbytheDiseaseActiv-
ity Score and C-reactive protein (DAS28-CRP). IL7R was
one of the notably expressed associated with DAS28-CRP in
the evaluation of the peripheral blood expression of genes
regulated by NF-κB, a key mediator of tumor necrosis factor-
alpha (TNF-alpha) signaling, in patients with RA before
and during treatment with anti-TNF-alpha or methotrexate
(MTX). These results identify candidate markers, such as
IL7R, that could lead to the development of a simple, min-
imally invasive pharmacodynamic assay for RA treatments
directed at the NF-κB pathway [55]. In our study, according
to the GeneSpring analysis, IL7R was down-regulated and
participated in T-cell regulation in cold-pattern RA patients
but not in heat-pattern RA patients. In this case, IL7R can
block apoptosis and promote the proliferation of CD4+
T cells in cold-pattern RA patients.
IL16 (Interleukin 16, a lymphocyte chemoattractant fac-
tor)isapleiotropiccytokinethatfunctionsasachemoattrac-
tant, a modulator of T-cell activation, and an inhibitor of
HIVreplication.Thesignalingprocessofthiscytokineisme-
diated by CD4. The product of this gene undergoes prote-
olytic processing, which yields two functional proteins. The
cytokine function is exclusively attributed to the secreted C-
terminalpeptide,andtheN-terminalproductmayplayarole
in cell cycle control. Caspase 3 is involved in the proteolytic
processing of this protein. Alternate splicing results in mul-
tiple transcript variants [56]. Many studies have shown thatEvidence-Based Complementary and Alternative Medicine 13
Table 9: GO-discovered categories for the genes that diﬀered between the heat pattern and the control.
GO ID GO name Number of genes P value Gene name
Biological process
GO:0006950 Response to stress 5 0.0235 CAMP, CD59, PRKAA1, HSPA1A, HSPA8
GO:0009607 Response to biotic stimulus 3 0.0287 CAMP, HSPA1A, HSPA8
GO:0006986 Response to unfolded protein 2 0.0492 HSPA1A, HSPA8
GO:0051789 Response to protein stimulus 2 0.0733 HSPA1A, HSPA8
Cellular constituent
GO:0030529 Ribonucleoprotein complex 4 0.0076 LSM6, HSPA1A, NCL, HSPA8
Molecular function
GO:0000166 Nucleotide binding 5 0.0205 ASCC3, PRKAA1, HSPA1A, NCL, HSPA8
GO:0005524 ATP binding 4 0.0357 ASCC3, PRKAA1, HSPA1A, HSPA8
GO:0032559 Adenyl ribonucleotide binding 4 0.0369 ASCC3, PRKAA1, HSPA1A, HSPA8
GO:0030554 Adenyl nucleotide binding 4 0.0423 ASCC3, PRKAA1, HSPA1A, HSPA8
GO:0001883 Purine nucleoside binding 4 0.0440 ASCC3, PRKAA1, HSPA1A, HSPA8
GO:0001882 Nucleoside binding 4 0.0447 ASCC3, PRKAA1, HSPA1A, HSPA8
GO:0051082 Unfolded protein binding 2 0.0592 HSPA1A, HSPA8
GO:0032553 Ribonucleotide binding 4 0.0623 ASCC3, PRKAA1, HSPA1A, HSPA8
GO:0032555 Purine ribonucleotide binding 4 0.0623 ASCC3, PRKAA1, HSPA1A, HSPA8
GO:0017076 Purine nucleotide binding 4 0.0695 ASCC3, PRKAA1, HSPA1A, HSPA8
IL16 plays a role in the disease process underlying RA and
jointdestruction[57–59].Inourstudy,IL16 wasdown-regu-
lated and participated in T-cell regulation with IL7R in cold-
pattern RA patients but not in heat pattern RA patients.
EIF4A2 (eukaryotic translation initiation factor 4A2) is
a gene for one of the protein-synthesis initiation factors
involved in the binding of mRNA to the ribosome [60]. One
study indicated that EIF4A2 controls mRNA-speciﬁc trans-
lation and the protein synthesis rate in pancreatic beta-cells
and that EIF4A2 is down-regulated by high glucose levels in
rat beta-INS832/13 cells [61]. In our study, according to the
PPI analysis, EIF4A2 as a seed gene was down-regulated in
cold-pattern RA patients and was related to the regulation
of translation and cell biosynthetic processes, but it was not
altered in heat-pattern RA patients.
For TCM heat-pattern RA patients, closely related path-
ways, including antigen processing and presentation, endo-
cytosis, MAPK signaling, RNA degradation, hematopoietic
cell lineage, complement and coagulation cascades, mTOR
signaling, adipocytokine signaling, regulation of autophagy,
hypertrophiccardiomyopathy(HCM),andinsulinsignaling,
were found. The diﬀerentially expressed major genes were
CAMP, PRKAA1, HSPA1A, HSPA8, and LSM6 in heat-pat-
tern RA patients.
CAMP (cathelicidin antimicrobial peptide) is an antimi-
crobial protein found in speciﬁc granules of polymorphonu-
clear leukocytes (PMNs) [62]. The cathelicidin family is cha-
racterized by a conserved N-terminal cathelin domain and
a variable C-terminal antimicrobial domain that can be re-
leased from the precursor protein after cleavage by protei-
nases [63]. In our study, CAMP was up-regulated 2.33-fold
and participated in T-cell regulation and cell proliferation in
TCM heat-pattern RA patients but not in cold-pattern RA
patients.
PRKAA1 (protein kinase, AMP-activated, alpha 1 cat-
alytic subunit) belongs to the ser/thr protein kinase family. It
is the catalytic subunit of the 5’-prime-AMP-activated pro-
teinkinase(AMPK).AMPK regulatestheactivitiesofanum-
ber of key metabolic enzymes through phosphorylation and
protects cells from stresses that cause ATP depletion by swit-
ching oﬀ ATP-consuming biosynthetic pathways [64]. It par-
ticipated in the mTOR signaling pathway, the adipocytokine
signaling pathway, the regulation of autophagy, hypertrophic
cardiomyopathy (HCM), and the insulin signaling pathway
of the KEGG pathway in heat-pattern, RA patients but not
in cold-pattern RA patients. According to the PPI analysis,
PRKAA1, as a seed gene, was up-regulated and participated
in fatty acid metabolism in TCM heat-pattern RA patients.
HSPA1A (heat shock 70kDa protein 1A) is a 70kDa heat
shock protein and a member of the heat shock protein 70
family. In conjunction with other heat shock proteins, this
protein stabilizes existing proteins against aggregation and
mediates the folding of newly translated proteins in the
cytosol and in organelles. It is also involved in the ubiquitin-
proteasome pathway through interaction with the AU-rich
element RNA-binding protein 1. It is located in the major
histocompatibility complex class III region in a cluster with
two closely related genes that encode similar proteins [65].
According to the GeneSpring analysis results, HSPA1A was
up-regulated and participated in spliceosome, antigen pro-
cessingandpresentation,endocytosis,MAPK signalingpath-
way, and prion diseases using the KEGG pathway and in T-
cell regulation in heat pattern RA patients. Based on the PPI
analysis results, it also participated in the I-κB kinase/NF-
κB cascade in heat pattern RA patients. HSPA8 (heat shock
70kDa protein 8) belongs to the heat shock protein 70
family, which contains both heat-inducible and constitu-
tively expressed members. The latter members are called14 Evidence-Based Complementary and Alternative Medicine
Table 10: The gene ontology analysis of the cold pattern versus control and the heat pattern versus control comparisons.
GO ID Description P value
Cold pattern versus control
Subnetworks A
6455 Translational elongation 4.26E-168
6416 Translation 6.96E-146
44249 Cell biosynthetic process 1.87E-104
9059 Macromolecule biosynthetic 8.699E-70
10467 Gene expression 1.156E-68
Subnetworks B
31145 Anaphase-promoting complex-dependent proteasomal
ubiquitin-depended protein catabolic process 4.326E-81
51436 Negative regulation of ubiquitin protein ligase activity during mitotic cell
cycle 4.326E-81
51352 Negative regulation of ligase activity 1.235E-80
51444 Positive regulation of ligase activity during mitotic cell cycle 1.235E-80
51437 Positive regulation of ligase activity 9.253E-80
Subnetworks C
6374 Nuclear mRNA splicing, via spliceosome 9.582E-17
375 RNA splicing, via transesteriﬁcation reactions 9.582E-17
377 RNA splicing, via transesteriﬁcation reactions with bulged adenosine as
nucleophile 9.582E-17
6395 RNA splicing 1.284E-14
6397 mRNA process 2.703E-14
Subnetworks D
7259 JAK-STAT cascade 2.231E-09
19221 Cytokine and chemokine mediated signaling pathway 1.603E-08
1553 Luteinization 5.211E-07
1779 Natural killer cell diﬀerentiation 5.211E-07
46544 Development of secondary male sexual characteristics 5.211E-07
Heat pattern versus control
Subnetworks E
31145 Anaphase-promoting complex-dependent proteasomal
ubiquitin-depended protein catabolic process 1.45E-105
51436 Negative regulation of ubiquitin protein ligase activity during mitotic cell
cycle 1.45E-105
51352 Negative regulation of ligase activity 4.16E-105
51444 Positive regulation of ligase activity during mitotic cell cycle 4.16E-105
51437 Positive regulation of ligase activity 3.14E-104
Subnetworks F
51101 Regulation of DNA binding 1.508E-05
51098 Regulation of binding 3.286E-05
43123 Positive regulation of I-κB kinase/NF-κB cascade 5.187E-05
9607 Response to biotic stimulus 5.593E-05
43122 Regulation of I-κB kinase/NF-κB cascade 6.457E-05
Subnetworks G
6395 RNA splicing 1.284E-14
6397 mRNA splicing 2.703E-14Evidence-Based Complementary and Alternative Medicine 15
Table 10: Continued.
GO ID Description P value
16071 mRNA metabolic process 7.908E-14
6394 RNA processing 1.458E-12
16070 RNA metabolic process 1.175E-10
Subnetworks H
6633 Fatty acid biosynthetic process 1.498E-09
46394 Carboxylic acid biosynthetic process 2.761E-09
16053 Organic acid biosynthetic process 2.761E-09
6631 Fatty acid metabolic process 7.384E-08
32787 Monocarboxylic acid metabolic process 2.767E-07
heat-shock cognate proteins. This gene encodes a heat-shock
cognate protein, which binds to nascent polypeptides to faci-
litatecorrectfolding.ItalsofunctionsasanATPaseinthedis-
assembly of clathrin-coated vesicles during the transport of
membrane components through the cell [66]. Similar to
HSPA1A, HSPA8 also participated in the spliceosome, anti-
gen processing and presentation, endocytosis, and MAPK
signaling pathway in heat-pattern RA patients. According to
the PPI analysis results, HSPA8,a sas e e dg e n e ,w a sd o w n -
regulated and also participated in the I-κB kinase/NF-κB
cascade in TCM heat-pattern RA patients. LSM6 is related to
Sm-like proteins, which form a stable heteromer that is pre-
sent in tri-snRNP particles, and is important for pre-mRNA
splicing [67]. According to the KEGG pathway, mRNA splic-
ing, and PPI analysis results, LSM6, as a seed gene, was up-
regulated and participated in the spliceosome and RNA deg-
radation in TCM heat-pattern RA patients.
We outlined the gene ontology relationship between the
TCM cold and heat patterns in RA patients (Figure 5)b y
ﬁrst combining the PPI results of interactions between TCM
cold and heat patterns (Figure 4) and then combining them
with all other data. In this network, common genes and bio-
logical processes and signiﬁcantly diﬀerent gene-based path-
ways and biological processes between the TCM cold- and
heat-pattern patients were identiﬁed, and these can be used
as biomarkers for the classiﬁcation of the two TCM RA
patterns. In the network, protein ubiquitination and RNA
splicing were the common biological processes in the TCM
coldandheatpatterns.ThediﬀerentbiomarkersfortheTCM
cold and heat patterns were obvious: the TCM cold pattern
was related to the regulation of translation and the Jak-
STAT cascade, and the TCM heat pattern was related to fatty
acid metabolism and the I-κB kinase/NF-κB cascade. In
addition, protein ubiquitination, proliferation and apoptosis
related to the cell cycle may be the connecting biological
processes between the TCM cold and heat patterns. CTLA4
andPSMD8werethesamesigniﬁcantbiomarkersinboththe
TCM cold and heat patterns. The signiﬁcant biomarkers for
t h eT C Mc o l dp a t t e r nc o u l db eEIF4A2, CCNT1, and IL7R,
and the signiﬁcant biomarkers for the TCM heat pattern
could be PRKAA1, HSPA8, and LSM6.
Thisstudyhassomelimitations,includingthelackofval-
idation by PCR or Western blotting or other clinical analysis
approaches for the microarray data. Because TCM pattern
classiﬁcation is based on an assemblage of multiple clinical
manifestations, including clinical signs and symptoms and
tongue and pulse appearances, the relevant biomedical net-
works are likely equally complex. Thus, various genes and
complicated interactions were included in the results, which
makes short-term validation of the results diﬃcult. However,
in this study, we use gene interaction analysis software (IPA)
to represent functional clusters of diﬀerent genes. Based on
theseﬁndings,additionalOmic(metabolicsandproteomics)
studieshavebeendesignedtovalidatethefunctionalclusters.
In addition, a more optimal study design, which includes
detailed aspects such as female menstruation, diet, and
activity controls, is warranted.
5. Conclusions
EIF4A2, CCNT1, and IL7R, which were related to the up-
regulation of cell proliferation and the Jak-STAT cascade,
were signiﬁcant gene biomarkers of the TCM cold pattern of
RA. PRKAA1, HSPA8, and LSM6, which were related to fatty
acid metabolism and the I-κB kinase/NF-κBc a s c a d e ,w e r e
signiﬁcant biomarkers of the TCM heat pattern of RA. The
network-basedgeneexpressionbiomarkersfortheTCMcold
and heat patterns may be helpful for the further stratiﬁcation
of RA patients when deciding on interventions or clinical
trials.
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